Emerging Paradigms in Insulin Resistance
| Emerging Paradigms in Insulin Resistance |
| Autore | Burke Susan J |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (190 p.) |
| Soggetto topico |
Biology, life sciences
Research & information: general |
| Soggetto non controllato |
acute intermittent porphyria
adipokines apoptosis beta hydroxybutyrate beta-hydroxybutyrate bone mineral density CAD severity carbohydrate loading therapy collagen diabetes endoplasmic reticulum stress epicardial adipose tissue experimental liver-targeted insulin fast-acting insulin fragility fractures genetic models glucagon glucagon-like peptide-1 glucosamine glucose intolerance glucose transporters hydroxyapatite hyperglycaemia hyperinsulinaemia hyperinsulinemia hypertrophy of adipocytes inflammation insulin receptor insulin resistance insulin-degrading enzyme liver metabolic disease metabolomics n/a Negr1 obesity osteocalcin osteocalin osteoporosis ovariectomy pancreas pancreatic β-cell dysfunction phenotype raloxifene serotonin stages thiazolidinedione type 2 diabetes vitamin D |
| ISBN | 3-0365-5366-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910619471703321 |
Burke Susan J
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Hereditary Hemorrhagic Telangiectasia : Recent Advances and Future Challenges
| Hereditary Hemorrhagic Telangiectasia : Recent Advances and Future Challenges |
| Autore | Mager Hans-Jurgen |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 online resource (228 p.) |
| Soggetto topico | Research and information: general |
| Soggetto non controllato |
activin receptor-like kinase 1 (ALK1)
activin-receptor-like kinase 1 ACVRL1 ALK1 angiogenesis antiangiogenic properties anticoagulants antiplatelets antithrombotic therapy arteriovenous malformation arteriovenous malformation (AVM) arteriovenous malformations (AVMs) AVM bazedoxifene bevacizumab biomarker biomarkers bleeding bone morphogenetic protein (BMP) catheter based embolization therapy cell adhesion cerebral ischemic lesions contrast enhanced magnetic resonance angiography endoglin Endoglin endothelial cells ENG epistaxis epistaxis severity score etamsylate FK506 gastrointestinal bleeding genetic disease genotype-phenotype correlation guidelines hereditary hemorrhagic hereditary hemorrhagic telangiectasia Hereditary hemorrhagic telangiectasia Hereditary Hemorrhagic Telangiectasia hereditary hemorrhagic telangiectasia (HHT) hereditary hemorrhagic telangiectasia (HHT), second-hit hereditary hemorrhagic telangiectasia/HHT/osler's disease HHT inflammation life expectancy liver long non-coding RNAs mechanical damage microRNA microRNAs MRI N-acetylcysteine nasal endoscopy nasal ointment non-coding RNAs nosebleeds Osler-Weber-Rendu pediatrics plasma propranolol propranolol gel pulmonary arteriovenous malformation pulmonary arteriovenous malformations raloxifene rare disease rare diseases safety screening shear stress Smad pathway Smad4 SMAD4 somatic mutation sun-induced trauma survival tacrolimus telangiectases telangiectasia telangiectasis tranexamic acid transcatheter embolotherapy transforming growth factor beta (TGF-β) transforming growth factor-beta (TGF-β) ultrasound vascular endothelial growth factor (VEGF) vascular injury vascular malformations |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Hereditary Hemorrhagic Telangiectasia |
| Record Nr. | UNINA-9910557578003321 |
Mager Hans-Jurgen
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||